Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Triacetylshikimic acid: a potent and safe oral antiplatelet agent

April 2, 2002

European Commission grants marketing approval for Arixtra

March 28, 2002

rNAPc2 safe and effective in phase IIa trial in patients undergoing PCI

March 26, 2002

Novel anticoagulants designed at 3-D

March 25, 2002

Scientists at Takeda present new factor Xa inhibitors

March 22, 2002

Bristol-Myers Squibb presents new compounds for the treatment of thrombosis

March 19, 2002

Lilly describes new series of factor Xa inhibitors

March 19, 2002

Merck & Co. reports new factor Xa and factor VIIa inhibitors

March 18, 2002

Aventis to study prolonged administration of Lovenox in prophylaxis of venous thromboembolism

March 18, 2002

Long-lasting oral antithrombotic efficacy demonstrated for AT-1015 in rat model

March 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...